Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: BMX-IN-1
  • Price: $316.8/10mg $853.6/50mg $1120.0/100mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1431525-23-3

1431525-23-3 structure
1431525-23-3 structure
  • Name: BMX-IN-1
  • Chemical Name: BMX-IN-1
  • CAS Number: 1431525-23-3
  • Molecular Formula: C29H24N4O4S
  • Molecular Weight: 524.590
  • Catalog: Biochemical Inhibitor Protein tyrosine kinase
  • Create Date: 2018-06-20 17:30:00
  • Modify Date: 2024-01-02 16:35:59
  • BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.

Name BMX-IN-1
Synonyms 2-Propenamide, N-[2-methyl-5-[9-[4-[(methylsulfonyl)amino]phenyl]-2-oxobenzo[h][1,6]naphthyridin-1(2H)-yl]phenyl]-
MFCD25372042
BMX-IN-1
N-{2-Methyl-5-[9-{4-[(methylsulfonyl)amino]phenyl}-2-oxobenzo[h][1,6]naphthyridin-1(2H)-yl]phenyl}acrylamide
Description BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.
Related Catalog
Target

IC50: 8 nM (BMX), 10.4 nM (BTK)

In Vitro BMX-IN-1 inhibits the proliferation of Tel-BMX-transformed Ba/F3 cells and RV-1 cells with IC50s of 25 nM and 2.53 μM. BMX-IN-1 exhibits remarkable selectivity with an S(10) score of 0.01. BMX-IN-1 inhibits only wild-type BMX with an IC50 of 138 nM. BMX-IN-1 requires covalent modification of Cys496 of BMX to achieve potent inhibition[1].
Cell Assay RV-1 cells in complete or serum-reduced DMEM are treated with DMSO, BMX-IN-1 (2.5 μM), MK2206 (200 nM), or the combination of BMX-IN-1 and MK2206 for 5 days before cells are harvested by trypsin and washed with cold PBS. The cells are then fixed in 70% cold ethanol (prechilled at −20°C) and incubated at 4°C overnight. On the day of flow cytometry, cells are collected by centrifugation, washed with PBS, and stained in 50 μg/mL propidium iodide + 0.5 mg/mL RNase in PBS + 0.5% Triton-X100 for 30 min at RT and moved to 4°C until the time of analysis. Flow cytometry is performed using a BD FACScan, and results are analyzed by ModFit software in the Flow Cytometry Core Facility in Dana-Faber Cancer Institute.
References

[1]. Feiyang Liu , et al. Discovery of a Selective Irreversible BMX Inhibitor for Prostate Cancer. ACS Chem. Biol., DOI: 10.1021/cb4000629

Density 1.4±0.1 g/cm3
Molecular Formula C29H24N4O4S
Molecular Weight 524.590
Exact Mass 524.151855
LogP 3.52
Index of Refraction 1.708
Storage condition 2-8℃